Thought Leadership

The FDA and the Future of AI Oversight

In January 2024, the U.S. Government Accountability Office (GAO) issued a report highlighting current obstacles to the U.S. Food and Drug Administration’s (FDA) timely and effective regulation of artificial intelligence (AI) and machine learning (ML) in medical devices and other emerging health care technologies (GAO...

View More

Manatt Represents A.G.P. in Chromocell Therapeutics Corp. $6.6M IPO

A Manatt team led by Capital Markets Partner Thomas J. Poletti represented Alliance Global Partners (A.G.P.) as the underwriter for Chromocell Therapeutics Corp.@s initial public offering (IPO), which raised $6.6 million. Chromocell Therapeutics, a company based in New Jersey, develops and sells non-opioid and non-addictive treatments for pain and other related medical conditions. Their IPO...

View More

AI Implemented Invention Tips Following USPTO Guidance

The United States Patent and Trademark Office (USPTO) and the Court of Appeals for the Federal Circuit have both previously held that an artificial intelligence (AI) system cannot be a sole inventor on a patent application since each inventor must be a human being.

View More

Manatt Represents Ennov in Acquisition of Calyx’s Enterprise Technology Division

A Manatt team, led by Venture Capital and Emerging Companies Partners Richard G.J. McDerby and Michel C. Narganes, along with Corporate and Finance Associate Adriana M. Bass, represented Ennov SAS in their acquisition of the...

View More

Double Trouble for Double Patenting or When Does My Patent Expire?

The Federal Circuit recently clarified the interplay between obvious-type double patenting (ODP) and patent term adjustments (PTA) granted pursuant to 35 U.S.C. § 154(b).

View More

Manatt Ventures VC Market Update – August 2023

The Manatt Ventures team constantly evaluates changes in the market, both for our clients and for the Manatt Venture Fund, our internal venture capital (VC) fund. Below are some of the more interesting data points and perspectives we have come across lately that have helped inform our perspectives.

View More

Advancing Women’s Reproductive Health Access: Medicaid Should Be a Part of Your Growth Strategy

Medicaid is a critical source of health care coverage for women in their childbearing years, covering 1 in 5, or 13 million, women of reproductive age.

View More

Getting the Most from Transformative Technologies

The second webinar in our innovation series will discuss how to get the most out of transformative technological change in healthcare.

View More

Health Care and Innovation: Why Not Better and Cheaper? Webinar Series

In a two-part webinar series, Manatt Health moderates a discussion with James Rebitzer and Robert Rebitzer—co-authors of a new book about innovation in health care, Why Not Better and Cheaper?—and a panel of industry leaders focused on boosting value and reducing costs in the health care system. 

View More

FTC and HHS Send Letter Warning of Risks From Online Tracking Technologies

On July 20, 2023, the OCR at the HHS and the FTC sent a joint letter to approximately 130 hospital systems and telehealth providers to alert them to the “serious privacy and security risks” stemming from the use of online tracking technologies integrated into their websites and mobile apps.

View More
Services








Key Topics




Clear